Download Draft 08

Moffitt Cancer Center and Oracle Health Sciences to Develop Next-Generation Health
and Research Informatics System
Secure Solution to Accelerate Translational Research and Support Personalized Clinical Trials
Redwood Shores, Calif. – March 30, 2011
News Facts
 To support translational research and accelerate the development of personalized
cancer care, Moffitt Cancer Center, a National Cancer Institute (NCI) Comprehensive
Cancer Center and leading translational research center, has selected Oracle Health
Sciences solutions as the foundation for its next-generation Health and Research
Informatics platform.
 The new informatics environment will support Moffitt’s Total Cancer Care™ program by
generating new intelligence from existing systems. Securely synthesizing data from
numerous clinical sources, a state-of-the-art biobank, and patient-reported information,
the Oracle solution will deliver rapid and accurate analysis that reveals new insight
around treatment effectiveness at an individual level, helping to advance personalized
medicine initiatives.
 Moffitt selected Oracle® Health Sciences Enterprise Healthcare Analytics suite and
Oracle Healthcare Master Person Index – along with Oracle Fusion Middleware
components and Oracle Database 11g – to form the foundation of the new informatics
solution because of its scalability and security, as well as its unparalleled analytics
capabilities and data model.
 By standardizing on the Oracle Healthcare Data Warehouse Foundation data model and
using Oracle software, Moffitt will also gain the ability to normalize, aggregate and
analyze data – ranging from molecular information to patient outcomes – from internal
and external sources to identify new predictive biomarkers, treatment best practices and
more effective therapies for individual patients.
 Moffitt’s new informatics environment will also help it to rapidly expand the number of
health systems contributing to its Total Cancer Care collection of longitudinal data and
patient bio-specimens while strengthening its commitment to patient privacy and
information security. Increasing the volume of data available for analysis will enable
Moffitt to identify and validate targeted patient populations for cancer trials and thereby
improve clinical trial efficiency and productivity.
Supporting Quotes
 “To implement a new paradigm of care that enables more personalized and targeted
treatments, health sciences organizations require new ways to effectively capture data
and meaningfully analyze and reuse it,” said Neil de Crescenzo, senior vice president
and general manager, Oracle Health Sciences. “Moffitt’s Total Cancer Care is an
innovative initiative to accelerate personalized medicine that can be expanded and
applied to many diseases. We are proud to team with Moffitt to help build the nextgeneration informatics environment to support this new paradigm.”
 “Advances in science and technology promise to fundamentally transform the way we
treat patients with cancer and other complex diseases,” said William S. Dalton, Ph.D.,
M.D., CEO and Center Director, Moffitt Cancer Center. “However, this transformation

will only be possible through the synergy of healthcare information technology with
scientific breakthroughs in the molecular understanding of disease, novel therapeutics
and diagnostics, as well as a fundamental redesign of our healthcare delivery models.
Leveraging longitudinal data from multiple sources and diverse populations, in particular
our new wealth of outcomes information, will be essential. Oracle Health Sciences
shares our vision and commitment to enabling this change through effective enterprise
analytics.”
“Oracle’s solutions for health sciences, along with Oracle Database and Oracle Fusion
Middleware, will enable us to surmount two fundamental health science informatics
challenges – data integration and analysis – to identify predictive biomarkers that will
lead to more personalized treatments for our patients,” said Mark Hulse, R.N., Vice
President Information Services and Chief Information Officer, Moffitt Cancer Center.
“Today’s standard electronic medical records alone will not support the research and
care required to truly personalize cancer care. Oracle Enterprise Healthcare Analytics
will enable us to advance our ability to aggregate clinical and genotypic data to support
translational research and improve patient care.”
Supporting Resources
 Oracle in Health Sciences
 Follow Oracle Health Sciences on Twitter
 Join the Oracle Health Sciences Community on Facebook
About Oracle
Oracle is the world’s most complete, open and integrated business software and hardware
systems company. For more information about Oracle, please visit our Web site at
http://www.oracle.com.
About Moffitt Cancer Center
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a
designation that recognizes Moffitt’s excellence in research and contributions to clinical trials,
prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia, one
in Pennsylvania and two in Puerto Rico. Additionally, Moffitt is a member of the National
Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers,
and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer.
Moffitt marks a very important anniversary this year – 25 years committed to one mission: to
contribute to the prevention and cure of cancer.
Trademark
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be
trademarks of their respective owners.
###
Contact Info
Greg Lunsford
Oracle
+1.650.506.6523
[email protected]
Michelle Foley
Moffitt Cancer Center
(813) 745-1505
[email protected]
Mary Tobin
O’Keeffe & Company
+1.503.658.7396
[email protected]